Clinical Trials Browser

Phase 4 × Octreotide × 1 year × Clear all

NCT07262957 2025-12-22

PANENCA

Phase 4 Recruiting

Gastrointestinal

Pancreatic Intraductal Neoplasms, Duodenal Neoplasms, Fistula, Pancreatitis

NCT03289741 2025-05-09

A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide

Phase 4 Completed

51 enrolled 10 charts

Neuroendocrine Tumors